Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SPARTALIZUMAB vs SUCCINYLCHOLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SPARTALIZUMAB vs SUCCINYLCHOLINE: Safety Overview

Metric SPARTALIZUMAB SUCCINYLCHOLINE
Total FAERS Reports 288 2,347
Deaths Reported 23 216
Death Rate 8.0% 9.2%
Hospitalizations 235 714
Average Patient Age 61.1 yrs 45.0 yrs
% Female Patients 59.2% 59.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Somerset Therapeutics, LLC
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued